Cargando…

Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy

CASES: Septic cardiomyopathy is defined as a reversible left ventricular systolic dysfunction. Patients with severe septic cardiomyopathy have a high mortality rate, even if they receive conventional therapy. For those patients, previous reports showed intra‐aortic balloon pump (IABP) efficacy. We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiromi, Taro, Toida, Chiaki, Muguruma, Takashi, Hashiba, Katsutaka, Doi, Tomoki, Nakamura, Kyota, Morimura, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649302/
https://www.ncbi.nlm.nih.gov/pubmed/29123906
http://dx.doi.org/10.1002/ams2.292
_version_ 1783272529850269696
author Hiromi, Taro
Toida, Chiaki
Muguruma, Takashi
Hashiba, Katsutaka
Doi, Tomoki
Nakamura, Kyota
Morimura, Naoto
author_facet Hiromi, Taro
Toida, Chiaki
Muguruma, Takashi
Hashiba, Katsutaka
Doi, Tomoki
Nakamura, Kyota
Morimura, Naoto
author_sort Hiromi, Taro
collection PubMed
description CASES: Septic cardiomyopathy is defined as a reversible left ventricular systolic dysfunction. Patients with severe septic cardiomyopathy have a high mortality rate, even if they receive conventional therapy. For those patients, previous reports showed intra‐aortic balloon pump (IABP) efficacy. We report two rare cases with IABP introduction leading them to drastic improvement, and survival from severe septic cardiomyopathy. Case 1 is a 78‐year‐old woman diagnosed with renal calculus pyelonephritis, septic shock, and septic cardiomyopathy. Case 2 is a 62‐year‐old man diagnosed with pneumonia, septic shock, and septic cardiomyopathy. OUTCOME: In both cases, despite conventional therapy for cardiomyopathy, including high‐dose catecholamine therapy, shock was not reversed, and the IABP was inserted. Circulatory status was improved after the introduction of the IABP. CONCLUSION: Our findings suggest that an IABP can be useful for salvaging patients with septic cardiomyopathy who do not respond to conventional therapy.
format Online
Article
Text
id pubmed-5649302
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56493022017-11-09 Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy Hiromi, Taro Toida, Chiaki Muguruma, Takashi Hashiba, Katsutaka Doi, Tomoki Nakamura, Kyota Morimura, Naoto Acute Med Surg Case Reports CASES: Septic cardiomyopathy is defined as a reversible left ventricular systolic dysfunction. Patients with severe septic cardiomyopathy have a high mortality rate, even if they receive conventional therapy. For those patients, previous reports showed intra‐aortic balloon pump (IABP) efficacy. We report two rare cases with IABP introduction leading them to drastic improvement, and survival from severe septic cardiomyopathy. Case 1 is a 78‐year‐old woman diagnosed with renal calculus pyelonephritis, septic shock, and septic cardiomyopathy. Case 2 is a 62‐year‐old man diagnosed with pneumonia, septic shock, and septic cardiomyopathy. OUTCOME: In both cases, despite conventional therapy for cardiomyopathy, including high‐dose catecholamine therapy, shock was not reversed, and the IABP was inserted. Circulatory status was improved after the introduction of the IABP. CONCLUSION: Our findings suggest that an IABP can be useful for salvaging patients with septic cardiomyopathy who do not respond to conventional therapy. John Wiley and Sons Inc. 2017-07-13 /pmc/articles/PMC5649302/ /pubmed/29123906 http://dx.doi.org/10.1002/ams2.292 Text en © 2017 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Hiromi, Taro
Toida, Chiaki
Muguruma, Takashi
Hashiba, Katsutaka
Doi, Tomoki
Nakamura, Kyota
Morimura, Naoto
Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title_full Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title_fullStr Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title_full_unstemmed Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title_short Two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
title_sort two cases with intra‐aortic balloon pumping use for severe septic cardiomyopathy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649302/
https://www.ncbi.nlm.nih.gov/pubmed/29123906
http://dx.doi.org/10.1002/ams2.292
work_keys_str_mv AT hiromitaro twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT toidachiaki twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT mugurumatakashi twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT hashibakatsutaka twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT doitomoki twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT nakamurakyota twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy
AT morimuranaoto twocaseswithintraaorticballoonpumpinguseforseveresepticcardiomyopathy